AU6246198A - 4-aminoethoxyindazole derivatives - Google Patents

4-aminoethoxyindazole derivatives

Info

Publication number
AU6246198A
AU6246198A AU62461/98A AU6246198A AU6246198A AU 6246198 A AU6246198 A AU 6246198A AU 62461/98 A AU62461/98 A AU 62461/98A AU 6246198 A AU6246198 A AU 6246198A AU 6246198 A AU6246198 A AU 6246198A
Authority
AU
Australia
Prior art keywords
aminoethoxyindazole
derivatives
aminoethoxyindazole derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU62461/98A
Inventor
Richard Eric Mewshaw
Anthonie Johan Verwijs
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wyeth LLC
Original Assignee
American Home Products Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by American Home Products Corp filed Critical American Home Products Corp
Publication of AU6246198A publication Critical patent/AU6246198A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/54—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings condensed with carbocyclic rings or ring systems
    • C07D231/56—Benzopyrazoles; Hydrogenated benzopyrazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Psychiatry (AREA)
  • Psychology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
AU62461/98A 1997-02-18 1998-01-13 4-aminoethoxyindazole derivatives Abandoned AU6246198A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US80132597A 1997-02-18 1997-02-18
US08801325 1997-02-18
PCT/US1998/001167 WO1998035942A1 (en) 1997-02-18 1998-01-13 4-aminoethoxyindazole derivatives

Publications (1)

Publication Number Publication Date
AU6246198A true AU6246198A (en) 1998-09-08

Family

ID=25180801

Family Applications (2)

Application Number Title Priority Date Filing Date
AU62461/98A Abandoned AU6246198A (en) 1997-02-18 1998-01-13 4-aminoethoxyindazole derivatives
AU62733/98A Abandoned AU6273398A (en) 1997-02-18 1998-02-13 4-aminoethoxyindazole derivatives

Family Applications After (1)

Application Number Title Priority Date Filing Date
AU62733/98A Abandoned AU6273398A (en) 1997-02-18 1998-02-13 4-aminoethoxyindazole derivatives

Country Status (11)

Country Link
EP (1) EP0960101A1 (en)
JP (1) JP2001512458A (en)
KR (1) KR20000071125A (en)
CN (1) CN1248246A (en)
AR (1) AR011137A1 (en)
AU (2) AU6246198A (en)
BR (1) BR9807397A (en)
CA (1) CA2278746A1 (en)
IL (1) IL131159A0 (en)
WO (2) WO1998035942A1 (en)
ZA (1) ZA981307B (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005116027A2 (en) * 2004-05-26 2005-12-08 Pfizer Limted Indazole and indolone derivatives and their use as pharmaceuticals
AU2015341913B2 (en) * 2014-11-03 2020-07-16 Iomet Pharma Ltd Pharmaceutical compound

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9305623D0 (en) * 1993-03-18 1993-05-05 Merck Sharp & Dohme Therapeutic agents
GB9305641D0 (en) * 1993-03-18 1993-05-05 Merck Sharp & Dohme Therapeutic agents

Also Published As

Publication number Publication date
AR011137A1 (en) 2000-08-02
IL131159A0 (en) 2001-01-28
BR9807397A (en) 2000-03-14
CA2278746A1 (en) 1998-08-20
KR20000071125A (en) 2000-11-25
AU6273398A (en) 1998-09-08
WO1998035942A1 (en) 1998-08-20
CN1248246A (en) 2000-03-22
WO1998035943A1 (en) 1998-08-20
JP2001512458A (en) 2001-08-21
EP0960101A1 (en) 1999-12-01
ZA981307B (en) 1999-08-17

Similar Documents

Publication Publication Date Title
AU1151099A (en) Azaoxindole derivatives
AU1825899A (en) Dota-biotin derivatives
AU7935398A (en) Diaminorhodamine derivatives
AU6117998A (en) 3-oxadiazolylquinoxaline derivatives
AU1709299A (en) Mixer-injectors
AU1735497A (en) Sulfonylureidopyrazole derivatives
AU1027499A (en) 32P-polyphosphazene
AU3867997A (en) Chromene-3-carboxylate derivatives
AU2956097A (en) Alkylaminobenzothiazole and -benzoxazole derivatives
EP1008579A3 (en) Cyclopentenebutanol derivatives
AU5272198A (en) EMP-charge-eliminator
AU7813598A (en) Betulinol derivatives
AU4962097A (en) 2-methoxyphenylpiperazine derivatives
AU4117497A (en) Micropolarimeter
AU6729498A (en) Thiazolimine derivatives
AU1174199A (en) Biphenylamidine derivatives
AUPO863197A0 (en) Novel derivatives
AU1793197A (en) Pyrazole-4-yl-hetaroyl derivatives
AU6185898A (en) Clavaspirins
AU3685097A (en) N-benzylazolium derivatives
AU1562199A (en) Amino-benzothiazole derivatives
AU6115798A (en) Saponarin derivatives
AU1691399A (en) 5-arylpyrrole derivatives
AU2123797A (en) 2-thioxotetrahydropyrimidin-4-one derivatives
AU7873198A (en) Polysaccharide-peptide derivatives